Venus Medtech Statements
25
Venus Medtech Income Statement
B
M
CNY (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
235.76
100
47.807
20.3
187.96
79.7
187.58
79.6
206.59
87.6
516.01
218.9
-328.05
-139.1
-36.948
-15.7
—
0
-365
-154.8
-2.16
-0.9
-353.57
-150
-0.807
437.9
255.61
100
54.361
21.3
201.25
78.7
259.45
101.5
245.46
96
533.44
208.7
-332.19
-130
-38.149
-14.9
—
0
-370.34
-144.9
-4.124
-1.6
-350.19
-137.0009
-0.8
437.9
196.5
100
46.673
23.8
149.82
76.2
275.27
140.1
274.46
139.7
1 015.81
517
-865.99
-440.7
-25.573
-13.01
—
0
-909.94
-463.08
-27.564
-14.03
-857.77
-436.5
-1.955
438.81
209.97
100
45.79
21.8
164.18
78.2
177.4
84.5
181.7
86.5
377.59
179.8
-213.41
-101.6
-32.993
-15.7
—
0
-246.41
-117.4
-6.738
-3.2
-199.93
-95.2
-0.458
436.99
176.59
100
40.337
22.8
136.26
77.2
154.01
87.2
200.81
113.7
390.5
221.1
-254.25
-144
-6.109
-3.5
—
0
-260.34
-147.4
-6.165
-3.5
-260.57
-147.6
-0.594
438.93
239.27
100
51.181
21.4
188.09
78.6
104.33
43.6
143.84
60.1
294.6
123.1
-106.51
-44.5
-7.507
-3.1
—
0
-117.21
-49
0.004
0.002
-113.06
-47.3
-0.258
438.22
174
100
31.805
18.3
142.19
81.7
99.644
57.3
152.27
87.5
285.24
163.9
-143.05
-82.2
-0.263
-0.2
—
0
-142.31
-81.8
-2.984
-1.7
-138.47
-79.6
-0.334
415.11
102.05
100
16.962
16.6
85.087
83.4
67.607
66.2
86.37
84.6
124.33
121.8
-39.241
-38.5
-3.339
-3.3
—
0
-43.529
-42.7
0.009
0.009
-43.524
-42.7
-0.108
403.42